AB-L has received speaker fees from AstraZeneca, HAL Allergy, Novartis, Nycomed and Torrex Chiesi. AD declares no competing interests. At the time of study completion, KM and HM were employees of Mundipharma Research Limited, which funded the study and is financing the article-processing charge...